California Public Employees Retirement System
LGND icon

California Public Employees Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History

California Public Employees Retirement System’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-47,128
Closed -$4.48M – 2296
2021
Q1 		$4.48M Sell
47,128
-4,365
-8% -$413K ﹤0.01% 1497
2020
Q4 		$3.19M Sell
51,493
-962
-2% -$54.8K ﹤0.01% 1698
2020
Q3 		$3.12M Buy
52,455
+1,282
+3% +$87.5K ﹤0.01% 1564
2020
Q2 		$3.57M Sell
51,173
-9,962
-16% -$632K ﹤0.01% 1421
2020
Q1 		$2.77M Sell
61,135
-100,510
-62% -$5.7M ﹤0.01% 1397
2019
Q4 		$10.5M Buy
161,645
+98,275
+155% +$6.57M 0.01% 934
2019
Q3 		$3.94M Buy
63,370
+17,508
+38% +$1.1M ﹤0.01% 1450
2019
Q2 		$3.27M Sell
45,862
-2,310
-5% -$170K ﹤0.01% 1385
2019
Q1 		$3.78M Sell
48,172
-15,400
-24% -$1.17M ﹤0.01% 1343
2018
Q4 		$5.38M Sell
63,572
-2,252
-3% -$240K 0.01% 1082
2018
Q3 		$11.3M Buy
65,824
+1,741
+3% +$262K 0.01% 828
2018
Q2 		$8.28M Sell
64,083
-5,292
-8% -$591K 0.01% 998
2018
Q1 		$7.15M Buy
69,375
+2,057
+3% +$203K 0.01% 1101
2017
Q4 		$5.75M Buy
67,318
+875
+1% +$75.8K 0.01% 1287
2017
Q3 		$5.64M Buy
66,443
+3,285
+5% +$260K 0.01% 1234
2017
Q2 		$4.78M Buy
63,158
+2,725
+5% +$191K 0.01% 1308
2017
Q1 		$3.99M Sell
60,433
-321
-0.5% -$21.1K 0.01% 1438
2016
Q4 		$3.85M Sell
60,754
-9,778
-14% -$617K 0.01% 1459
2016
Q3 		$4.49M Sell
70,532
-13,145
-16% -$965K 0.01% 1382
2016
Q2 		$6.23M Buy
83,677
+2,405
+3% +$178K 0.01% 1135
2016
Q1 		$5.43M Sell
81,272
-16,992
-17% -$1.03M 0.01% 1224
2015
Q4 		$6.65M Buy
98,264
+5,771
+6% +$356K 0.01% 1078
2015
Q3 		$4.94M Buy
92,493
+6,412
+7% +$389K 0.01% 1276
2015
Q2 		$5.42M Buy
86,081
+11,061
+15% +$604K 0.01% 1322
2015
Q1 		$2.74M Hold
75,020
– – ﹤0.01% 1877
2014
Q4 		$2.74M Sell
75,020
-12,788
-15% -$416K ﹤0.01% 1877
2014
Q3 		$2.57M Hold
87,808
– – ﹤0.01% 1905
2014
Q2 		$3.41M Buy
87,808
+11,345
+15% +$460K ﹤0.01% 1752
2014
Q1 		$3.16M Hold
76,463
– – ﹤0.01% 1786
2013
Q4 		$2.6M Buy
76,463
+75,174
+5,832% +$2.45M ﹤0.01% 1898
2013
Q3 		$35K Sell
1,289
-16,350
-93% -$460K ﹤0.01% 3647
2013
Q2 		$412K Buy
+17,639
New +$317K ﹤0.01% 2774

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

California Public Employees Retirement System's LGND Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 47,128 shares — an estimated $4.48M sold.

California Public Employees Retirement System first reported a position in LGND in Q2 2013 and held it in 32 quarters. The position peaked at $11.3M in Q3 2018. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 47,128 Ligand Pharmaceuticals shares in Q2 2021, an estimated $4.48M.
  • California Public Employees Retirement System first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 32 quarters.
  • California Public Employees Retirement System's Ligand Pharmaceuticals position peaked at $11.3M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.